Beaumont RCSI Cancer Centre
Beaumont, Dublin, D09V2N0, Ireland
Location status: Recruiting
NCT Number: NCT07672392
All patients undergoing mastectomy for breast cancer should be offered the option of reconstructive surgery. The Deep Inferior Epigastric Perforator Flap or DIEP reconstruction as it is commonly referred to, is becoming the favoured reconstruction by both patients and surgeons as it gives a great cosmetic outcome as well as being a good option for patients who may have to undergo radiotherapy treatment after their surgery.
Exercise has been demonstrated in previous research to improve tolerance of treatment (particularly chemotherapy), post operative fatigue and the overall quality of life in patients undergoing cancer treatment. Furthermore, it has shown to improve survival in patients who are being treated for breast cancer. The investigators are undertaking this study to investigate whether a structured exercise programme will improve patients fitness after surgery and ultimately improve their recovery after their reconstructive surgery. To do this, half of the people taking part will be undertaking a structured exercise programme and the other half will not and will be assessing which group recover better after their surgery. Currently, no breast reconstruction patients in Ireland are receiving a formal "exercise prescription" after their surgery so will be looking to see if this helps people recover better before it is made standard care for every breast patient in Ireland.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Beaumont, Dublin, D09V2N0, Ireland
Location status: Recruiting
Primary Objective:
To evaluate the impact of a structured, post-operative exercise programme on patient-reported and functional outcomes following DIEP flap breast reconstruction.
Secondary Objectives:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Structured individualised 12-week post operative exercise programme based on ACSM oncology guidelines, incorporating aerobic, resistance and flexibility training delivered in person or via zoom.
Time frame: Measured at baseline (recruitment), 6 months postoperatively and at 1 year postoperatively
Cardiorespiratory fitness measured using the 6-Minute Walk Test (6MWT). Outcome reported as change in distance walked (metres) from baseline to 6 months post-operatively. Greater distance indicates improved cardiorespiratory fitness.
Time frame: 6 months and 12 months post operatively
Measured using a hand dynamometer and reported in kilograms.
Time frame: At six months and 12 months postoperatively
Body mass index (BMI) calculated from measured weight and height and reported in kilograms per square meter (kg/m²).
Time frame: At 6 months and 12 months post operatively
Quality of Life and Psychosocial Health: Assessed using the BREAST-Q (psychosocial and sexual well-being domains)
Time frame: At 6 months and 12 months postoperatively
Percentage body fat measured using bioelectrical impedance analysis with a Tanita device and reported as percentage body fat (%).
Time frame: At 6 months and 12 months postoperatively
Muscle mass measured using bioelectrical impedance analysis with a Tanita device and reported in kilograms (kg).
Time frame: At 6 months and 12 months postoperatively
Bone mass measured using bioelectrical impedance analysis with a Tanita device and reported in kilograms (kg).
Time frame: Measured at 6 months and 1 year postoperatively.
Measured using the 30 second Sit to Stand Test
Contact information is provided by the study sponsor or research team.
Aisling Hegarty, PhD
CONTACT
Arnold Hill, MB, BCh, BAO, MCh, FRCSI
CONTACT
Royal College of Surgeons, Ireland
Other
Acronym: EXERCISE DIEP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04088708
Behavior, Breast Cancer
Birmingham, Alabama, United States
View Trial DetailsNCT04207359
Atrophy, Behavior
San Antonio, Texas, United States
View Trial DetailsNCT04618120
Behavior, Breast Cancer
Ankara, Emek, Turkey (Türkiye)
View Trial DetailsNCT00877188
Behavior, Breast Cancer
Taipei, Taiwan
View Trial Details